Tomasz Czerw

17PUBLICATIONS
120CO-AUTHORS
Cardiovascular medicine and haematology not elsewhere classifiedTransplantation immunologyHaematologyRegenerative medicine (incl. stem cells)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Apr 01, 2026
Defining remission and relapse after allogeneic hematopoietic cell transplantation in myelodysplastic/myeloproliferative neoplasms and optimization of transplantation outcomes: Recommendations from the EBMT practice harmonisation and guidelines committee.

Christopher Armstrong, Kavita Raj, Giorgia Battipaglia

|Mar 07, 2026
Safe in transit: HSCT clinical outcomes unaffected by stem cell transport time.

Iwona Mitrus, Marcin Wilkiewicz, Wojciech Fidyk

|Oct 15, 2025
Transplant conditioning intensity (TCI) score predicts allo-HCT outcomes in patients with myelofibrosis: a study of the Chronic Malignancies Working Party of EBMT.

Patryk Sobieralski, Tomasz Czerw, Luuk Gras

|Aug 29, 2025
Impact of Donor Type on Outcomes After Allogeneic Hematopoietic Cell Transplantation in Myelofibrosis: A Study on Behalf of the Chronic Malignancies Working Party of the EBMT.

Juan Carlos Hernández-Boluda, Vipul Sheth, Simona Iacobelli

|Mar 27, 2025
Use of machine learning techniques to predict poor survival after hematopoietic cell transplantation for myelofibrosis.

Juan Carlos Hernández-Boluda, Adrián Mosquera-Orgueira, Luuk Gras

|Mar 19, 2025
Role of allo-HCT in "nonclassical" MPNs and MDS/MPNs: recommendations from the PH&G Committee and the CMWP of the EBMT.

Nicola Polverelli, Juan Carlos Hernández-Boluda, Francesco Onida

Pageof 3

Frequent Collaborators

14 joint publications

Juan-Carlos Hernández-Boluda

11 joint publications

Nicola Polverelli

11 joint publications

Marie Robin

7 joint publications

Ibrahim Yakoub-Agha